Seong-jin Yu

Miaoli, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Translational rehabilitation strategies for canine medial patellar luxation: insights from human patellofemoral pain syndrome.

Translational rehabilitation strategies for canine medial patellar luxation: insights from human patellofemoral pain syndrome.

Journal: Frontiers in veterinary science

Published: May 18, 2026

AAV-mediated intracerebral expression of an α-synuclein-targeting intrabody improves motor functions in aged rats.

AAV-mediated intracerebral expression of an α-synuclein-targeting intrabody improves motor functions in aged rats.

Journal: Scientific reports

Published: August 14, 2025

AAV-Mediated Expression of Methamphetamine Monoclonal Antibody Attenuates Methamphetamine Behaviour Sensitization in Mice.

AAV-Mediated Expression of Methamphetamine Monoclonal Antibody Attenuates Methamphetamine Behaviour Sensitization in Mice.

Journal: Addiction biology

Published: January 20, 2025

3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat.

3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat.

Journal: GeroScience

Published: January 16, 2025

Transplantation of Exosomes Derived From Human Wharton's Jelly Mesenchymal Stromal Cells Enhances Functional Improvement in Stroke Rats.

Transplantation of Exosomes Derived From Human Wharton's Jelly Mesenchymal Stromal Cells Enhances Functional Improvement in Stroke Rats.

Journal: Cell transplantation

Published: December 03, 2024

Neuroprotective effects of psilocybin in a rat model of stroke.

Neuroprotective effects of psilocybin in a rat model of stroke.

Journal: BMC neuroscience

Published: March 13, 2024

DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease.

DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease.

Journal: GeroScience

Published: December 12, 2023

Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders.

Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders.

Journal: GeroScience

Published: December 12, 2023

Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.

Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.

Journal: PloS one

Published: April 23, 2023

Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.

Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.

Journal: Scientific reports

Published: January 10, 2023

Herbal formula PM012 induces neuroprotection in stroke brain.

Herbal formula PM012 induces neuroprotection in stroke brain.

Journal: PloS one

Published: November 03, 2022

Alleviation of Methamphetamine Sensitization by Partially Lesioning Dopaminergic Terminals with 6-Hydroxydopamine in Nucleus Accumbens.

Alleviation of Methamphetamine Sensitization by Partially Lesioning Dopaminergic Terminals with 6-Hydroxydopamine in Nucleus Accumbens.

Journal: Cell transplantation

Published: November 08, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026